MATTHEW L. KAPLAN is Managing Director, Health Care Group – Equity Research, at Ladenburg Thalmann. He focuses on therapeutic companies, cardiovascular and drug delivery. Mr. Kaplan spent 13 years as a Biotechnology Analyst at PZ & Co., Evolution Capital and The Carson Group. He has six years of research experience with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology and has co-authored numerous articles on gene regulation in the heart. Mr. Kaplan holds a B.S. in biology from the University of Michigan.
Development In Biotech - Matthew L. Kaplan - Ladenburg Thalmann
October 19, 2009
New Approaches In Drug Delivery: Matthew Kaplan - Punk Ziegel & Co
September 29, 2003